2019 annual financial data
INmune Bio 2019 Financial results
Direct answer
Revenue was 77,688,000 USD.
Operating income was -7,756,001 USD and net income was -7,678,313 USD.
Operating cash flow was -5,384,656 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 77,688,000 USD
- Operating income
- -7,756,001 USD
- Net income
- -7,678,313 USD
- Operating cash flow
- -5,384,656 USD
Explore related company data
View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all INmune Bio financial years